GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 18, 2024
Displaying entries 2651 - 2700 of 40384 in total
PDB ID UniProt ID ▼ Title Descriptor
1R54 Q9BZ11 Crystal structure of the catalytic domain of human ADAM33
1R55 Q9BZ11 Crystal structure of the catalytic domain of human ADAM 33
7BH9 Q9BYF1 SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain
7FDG Q9BYF1 SARS-COV-2 Spike RBDMACSp6 binding to hACE2
7KJ2 Q9BYF1 SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
7NXC Q9BYF1 Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2
7EKH Q9BYF1 Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2
7SY0 Q9BYF1 Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
7V83 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
7V83 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
7V84 Q9BYF1 Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V84 Q9BYF1 Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V85 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
7V85 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
7V86 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
7V86 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
7V87 Q9BYF1 Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V87 Q9BYF1 Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V88 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
7V88 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
7V89 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
7V89 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
7V8A Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
7V8A Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
7V8B Q9BYF1 Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7V8B Q9BYF1 Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
7VX4 Q9BYF1 ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex
7VX5 Q9BYF1 ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex
7Y20 Q9BYF1 S-ECD (Omicron BA.3) in complex with two PD of ACE2
7Y21 Q9BYF1 S-ECD (Omicron BA.5) in complex with PD of ACE2
8WRH Q9BYF1 SARS-CoV-2 XBB.1.5.70 in complex with ACE2
8WRL Q9BYF1 XBB.1.5 RBD in complex with ACE2
8JYN Q9BYF1 Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state)
8JYO Q9BYF1 Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (2-up state)
8JYP Q9BYF1 Structure of SARS-CoV-2 XBB.1.5 spike RBD in complex with ACE2
7DDP Q9BYF1 Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD
7DX9 Q9BYF1 Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
7EKE Q9BYF1 Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2
7SXZ Q9BYF1 Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
7V81 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
7V81 Q9BYF1 Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
7TEW Q9BYF1 Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
7WHH Q9BYF1 Crystal structure of SARS-CoV-2 omicron RBD and human ACE2
7WS8 Q9BYF1 Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
7WS9 Q9BYF1 Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
7WSA Q9BYF1 Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
7ZF7 Q9BYF1 SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2
7DX5 Q9BYF1 S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound)
7FDI Q9BYF1 SARS-COV-2 Spike RBDMACSp36 binding to hACE2
7KJ4 Q9BYF1 SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024